Literature DB >> 31813228

Problem-Solving Therapy for Older Adults at Risk for Depression: A Qualitative Analysis of the Depression in Later Life Trial.

Fredric Azariah1, Miriam Sequeira1, Alex Cohen1, Amit Dias1, Jennifer Q Morse1, Stewart J Anderson1, Pim Cuijpers1, Vikram Patel1, Charles F Reynolds1.   

Abstract

OBJECTIVE: As a sequel to the Depression in Later Life trial of lay counselor-delivered problem-solving therapy for depression prevention among older adults in Goa, India, this qualitative study aimed to explore participant experiences to illuminate the reasons for the trial's positive findings and implications for further efforts at depression prevention in low-resource settings.
METHODS: In-depth interviews were conducted with 19 participants (21% of those randomly assigned to the original intervention). Two independent raters coded the data and organized narratives according to broad themes.
RESULTS: Most participants valued their relationship with the lay counselor, learned self-care strategies to cope with illnesses, and increased engagement in pleasurable social and physical activities. Some participants reported needing assistance with managing financial strain and family conflicts.
CONCLUSIONS: The lay-counselor-delivered intervention was well received. The relationship with the counselor and behavioral activation toward better self-care and more-pleasurable activities may have been keys to the intervention's success.

Entities:  

Keywords:  Depression prevention; lay counselor; low-resource setting

Mesh:

Year:  2019        PMID: 31813228     DOI: 10.1176/appi.psychotherapy.20190009

Source DB:  PubMed          Journal:  Am J Psychother        ISSN: 0002-9564


  1 in total

1.  Community-based mental health and well-being interventions for older adults in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Clarissa Giebel; Nipun Shrestha; Siobhan Reilly; Ross G White; Maria Isabel Zuluaga; Gabriel Saldarriaga; Ginger Liu; Dawn Allen; Mark Gabbay
Journal:  BMC Geriatr       Date:  2022-09-29       Impact factor: 4.070

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.